Annex 2 A. Regional profile: West Africa

Transcription

1 Annex 2 A. Regional profile: West Africa 355 million people at risk for malaria in million at high risk A. Parasite prevalence, 215 Funding for malaria increased from US$ 233 million to US$ 262 million >85 Not applicable case incidence decreased by 15% mortality rate reduced by 29% Zero countries eliminated malaria since 21 B. Share of estimated malaria cases, 215 Bukina Faso, 6% Ghana, 6% Benin, 3% Guinea, 4% Niger, 5% Mali, 7% Togo, 2% Côte d Ivoire, 7% Others, 5% Nigeria, 55% 7 WORLD MALARIA REPORT 216

2 C. Malaria funding by source, US$ (million) Domestic* Global Fund World Bank USAID UK Others Global Fund, Global Fund to Fight AIDS, Tuberculosis and Malaria; UK, United Kingdom of Great Britain and Northern Ireland; USAID, United States Agency for International Development E. Proportion of population sleeping under an ITN or protected with IRS, 215 Cabo Verde Ghana Guinea-Bissau Togo Côte d Ivoire Sierra Leone Benin Senegal Gambia Burkina Faso Mali Guinea Liberia Nigeria Niger Mauritania Algeria % 2% 4% 6% 8% 1% IRS, indoor residual spraying; ITN, insecticide-treated mosquito net ITN 215 IRS D. Malaria funding per person at risk, average Cabo Verde Liberia Gambia Ghana Benin Senegal Sierra Leone Mali Guinea-Bissau Nigeria Burkina Faso Guinea Côte d Ivoire Togo Niger Mauritania Algeria US$ Domestic* International F. Change in reported malaria incidence and mortality rates, milestone: -4% Incidence Mortality Liberia* Côte d Ivoire* Benin* Guinea* Ghana* Burkina Faso* Guinea-Bissau* Senegal* Niger* Sierra Leone* Togo* Nigeria* Gambia* Mauritania* Cabo Verde* Mali* Algeria* -1% -5% % 5% 1% f Reduction Increase p * Change in admission rate ( ) Countries in bold reported <2 indigenous malaria cases WORLD MALARIA REPORT

3 Annex 2 B. Regional profile: Central Africa 174 million people at risk for malaria in million at high risk A. Parasite prevalence, 215 Funding for malaria increased from US$ 65 million to US$ 116 million >85 case incidence decreased by 33% Not applicable B. Share of estimated malaria cases, 215 Others, 4% Burundi, 4% mortality rate reduced by 42% Zero countries eliminated malaria since 21 Central African Republic, 4% Chad, 6% Angola, 9% Cameroon, 16% Democratic Republic of the Congo, 57% 72 WORLD MALARIA REPORT 216

4 C. Malaria funding by source, D. Malaria funding per person at risk, average Domestic* Global Fund World Bank USAID UK Others Sao Tome and Principe Domestic* International Equatorial Guinea 4 Angola Gabon US$ (million) Democratic Republic of the Congo Burundi Central African Republic Chad Cameroon 21 Global Fund, Global Fund to Fight AIDS, Tuberculosis and Malaria; UK, United Kingdom of Great Britain and Northern Ireland; USAID, United States Agency for International Development E. Proportion of population sleeping under an ITN or protected with IRS, 215 Sao Tome and Principe* Burundi Chad Democratic Republic of the Congo Central African Republic Cameroon Angola Congo Equatorial Guinea Gabon % 2% 4% 6% 8% 1% IRS, indoor residual spraying; ITN, insecticide-treated mosquito net * Administrative ITN coverage ITN 215 IRS Congo US$ F. Change in reported malaria incidence and mortality rates, Central African* Republic* Gabon* Burundi* Democratic Republic* of the Congo* Chad* Angola* Cameroon* Sao Tome* and Principe* Congo* Equatorial Guinea* * Change in admission rate ( ) 22 milestone: -4% f Reduction Incidence Increase p Mortality -1% -5% % 5% 1% WORLD MALARIA REPORT

5 Annex 2 C. Regional profile: East and Southern Africa 319 million people at risk for malaria in million at high risk A. Parasite prevalence, 215 Funding for malaria decreased from US$ 156 million to US$ 15 million case incidence decreased by 22% B. Share of estimated malaria cases, 215 Others, 7% >85 Not applicable mortality rate reduced by 22% Zero countries eliminated malaria since 21 Madagascar, 5% Ethiopia, 6% Zambia, 6% Malawi, 7% Rwanda, 8% United Republic of Tanzania, 11% Kenya, 14% Uganda, 18% Mozambique, 18% 74 WORLD MALARIA REPORT 216

6 C. Malaria funding by source, US$ (million) Domestic* Global Fund World Bank USAID UK Others Global Fund, Global Fund to Fight AIDS, Tuberculosis and Malaria; UK, United Kingdom of Great Britain and Northern Ireland; USAID, United States Agency for International Development E. Proportion of population sleeping under an ITN or protected with IRS, 215 Swaziland* Botswana* Zimbabwe Madagascar Rwanda Mozambique Uganda Zambia Kenya Ethiopia South Sudan Comoros Malawi South Africa Namibia* United Republic of Tanzania (Zanzibar) United Republic of Tanzania (Mainland) Eritrea % 2% 4% 6% 8% 1% IRS, indoor residual spraying; ITN, insecticide-treated mosquito net * Administrative ITN coverage ITN 215 IRS D. Malaria funding per person at risk, average Swaziland Zambia Namibia Rwanda South Sudan Malawi Zimbabwe Mozambique United Republic of Tanzania South Africa Comoros Uganda Kenya Eritrea Madagascar Botswana Ethiopia US$ Domestic* International F. Change in reported malaria incidence and mortality rates, South Sudan* Namibia* Rwanda* Kenya* Madagascar* Malawi* United Republic of* Tanzania (Mainland)* Uganda* Zimbabwe* Mozambique* Swaziland* Ethiopia* Eritrea* Zambia* Botswana* United Republic of* Tanzania (Zanzibar)* South Africa* Comoros* * Change in admission rate ( ) 22 milestone: -4% f Reduction Incidence Increase p Mortality -1% -5% % 5% 1% WORLD MALARIA REPORT

7 Annex 2 D. Regional profile: Region of the Americas 132 million people at risk for malaria in million at high risk A. Confirmed malaria cases per 1 population, 215 Funding for malaria increased from US$ 17 million to US$ 21 million case incidence decreased by 31% Confirmed cases per 1 population Insufficient data > 1 B. Share of estimated malaria cases, 215 Guyana, 3% Others, 5% mortality rate reduced by 37% Colombia, 1% Haiti, 9% Venezuela (Bolivarian Republic of), 3% Three countries achieved zero indigenous cases for 3 years since 21 Peru, 19% Brazil, 24% 76 WORLD MALARIA REPORT 216

8 C. Malaria funding by source, US$ (million) Domestic* Global Fund World Bank USAID UK Others Global Fund, Global Fund to Fight AIDS, Tuberculosis and Malaria; UK, United Kingdom of Great Britain and Northern Ireland; USAID, United States Agency for International Development E. Proportion of cases due to P. falciparum and P. vivax, P. falciparum P. vivax Other Haiti Dominican Republic Colombia French Guiana Guyana Suriname Ecuador Venezuela (Bolivarian Republic of) Honduras Peru Nicaragua Brazil Bolivia (Plurinational State of) Guatemala Panama Belize El Salvador Mexico % 2% 4% 6% 8% 1% D. Malaria funding per person at risk, average Panama Suriname Mexico Peru El Salvador Colombia Brazil Guyana Nicaragua Venezuela (Bolivarian Republic of) Belize Dominican Republic Bolivia (Plurinational State of) Honduras Haiti Guatemala Ecuador French Guiana Domestic* US$ International F. Change in reported malaria incidence and mortality rates, Nicaragua Venezuela (Bolivarian Republic of) Peru Panama Guatemala Haiti Bolivia (Plurinational State of) Guyana Brazil Mexico Colombia Ecuador French Guiana Dominican Republic Honduras El Salvador Belize Suriname Incidence 22 milestone: -4% f Reduction Increase p Countries in bold reported <2 indigenous malaria cases Mortality -1% -5% % 5% 1% WORLD MALARIA REPORT

9 Annex 2 E. Regional profile: Eastern Mediterranean Region 291 million people at risk for malaria in million at high risk A. Confirmed malaria cases per 1 population/parasite prevalence (PP), 215 Funding for malaria decreased from US$ 55 million to US$ 45 million Confirmed cases per 1 population Insufficient data > 1 PP >85 Not applicable case incidence decreased by 11% B. Share of estimated malaria cases, 215 Yemen, 8% mortality rate reduced by 6% Afghanistan, 11% Somalia, 18% Sudan, 36% One country achieved zero indigenous cases for 3 years since 21 Pakistan, 27% 78 WORLD MALARIA REPORT 216

10 C. Malaria funding by source, D. Malaria funding per person at risk, average Domestic* Global Fund World Bank USAID UK Others Saudi Arabia Domestic* International Iran (Islamic Republic of) 15 Djibouti US$ (million) 1 Sudan Somalia 5 Afghanistan Yemen 21 Global Fund, Global Fund to Fight AIDS, Tuberculosis and Malaria; UK, United Kingdom of Great Britain and Northern Ireland; USAID, United States Agency for International Development E. Proportion of cases due to P. falciparum and P. vivax, Saudi Arabia Djibouti Yemen Somalia Sudan Pakistan Iran (Islamic Republic of) Afghanistan P. falciparum P. vivax Other % 2% 4% 6% 8% 1% Pakistan US$ F. Change in reported malaria incidence and mortality rates, Djibouti Saudi Arabia Afghanistan Somalia Pakistan Sudan Yemen Iran (Islamic Republic of) 22 milestone: -4% f Reduction Incidence Increase p Countries in bold reported <2 indigenous malaria cases Mortality -1% -5% % 5% 1% WORLD MALARIA REPORT

11 Annex 2 F. Regional profile: South-East Asia Region 1.4 billion people at risk for malaria in million at high risk Funding for malaria decreased from US$ 17 million to US$ 92 million A. Confirmed malaria cases per 1 population, 215 Confirmed cases per 1 population Insufficient data > 1 Not applicable case incidence decreased by 54% B. Share of estimated malaria cases, 215 Myanmar, 2% Others, % mortality rate reduced by 46% Indonesia, 9% India, 89% One country achieved zero indigenous cases for 3 years since 21 8 WORLD MALARIA REPORT 216

12 C. Malaria funding by source, D. Malaria funding per person at risk, average Domestic* Global Fund World Bank USAID UK Others Timor-Leste Domestic* International 3 Bhutan US$ (million) Myanmar Bangladesh Thailand Democratic People s Republic of Korea Indonesia 5 Nepal 21 Global Fund, Global Fund to Fight AIDS, Tuberculosis and Malaria; UK, United Kingdom of Great Britain and Northern Ireland; USAID, United States Agency for International Development E. Proportion of cases due to P. falciparum and P. vivax, Bangladesh Myanmar India Timor-Leste Indonesia Thailand P. falciparum P. vivax Other India US$ F. Change in reported malaria incidence and mortality rates, India Democratic People s Republic of Korea Indonesia Myanmar Nepal Thailand 22 milestone: -4% Incidence Mortality Bhutan Nepal Democratic People s Republic of Korea % 2% 4% 6% 8% 1% Bangladesh Bhutan Timor-Leste -1% -5% % 5% 1% f Reduction Increase p Countries in bold reported <2 indigenous malaria cases WORLD MALARIA REPORT

13 Annex 2 G. Regional profile: Western Pacific Region 74 million people at risk for malaria in million at high risk Funding for malaria increased from US$ 29 million to US$ 5 million A. Confirmed malaria cases per 1 population, 215 Confirmed cases per 1 population Insufficient data > 1 Not applicable case incidence decreased by 3% B. Share of estimated malaria cases, 215 Solomon Islands, 3% Others, 3% mortality rate reduced by 58% Zero countries eliminated malaria since 21 Lao People s Democratic Republic, 7% Cambodia, 1% Papua New Guinea, 77% 82 WORLD MALARIA REPORT 216

14 C. Malaria funding by source, D. Malaria funding per person at risk, average Domestic* Global Fund World Bank USAID UK Others Malaysia Domestic* International Vanuatu 15 Solomon Islands Papua New Guinea US$ (million) 1 5 Cambodia Lao People s Democratic Republic Philippines Viet Nam Republic of Korea 21 Global Fund, Global Fund to Fight AIDS, Tuberculosis and Malaria; UK, United Kingdom of Great Britain and Northern Ireland; USAID, United States Agency for International Development E. Proportion of cases due to P. falciparum and P. vivax, Philippines Papua New Guinea Cambodia Viet Nam Solomon Islands Lao People s Democratic Republic China Vanuatu Malaysia Republic of Korea P. falciparum P. vivax Other % 2% 4% 6% 8% 1% China US$ F. Change in reported malaria incidence and mortality rates, Lao People s Democratic Republic Cambodia Solomon Islands Viet Nam Republic of Korea Malaysia Philippines Papua New Guinea* Vanuatu 22 milestone: -4% Incidence Mortality China -1% -5% % 5% 1% f Reduction Increase p * Change in admission rate ( ) Countries in bold reported <2 indigenous malaria cases WORLD MALARIA REPORT